These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9787281)

  • 21. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
    Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
    Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
    Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical analysis of resectable breast cancer: a report of 6 263 cases].
    Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J
    Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elderly breast cancer patients treated by conservative surgery alone plus adjuvant tamoxifen: fifteen-year results of a prospective study.
    Martelli G; Miceli R; Costa A; Coradini D; Zurrida S; Piromalli D; Vetrella G; Greco M
    Cancer; 2008 Feb; 112(3):481-8. PubMed ID: 18098268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
    Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
    Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature.
    Caliskan M; Gatti G; Sosnovskikh I; Rotmensz N; Botteri E; Musmeci S; Rosali dos Santos G; Viale G; Luini A
    Breast Cancer Res Treat; 2008 Dec; 112(3):513-21. PubMed ID: 18240020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined ovarian ablation and aromatase inhibition as first-line therapy for hormone receptor-positive metastatic breast cancer in premenopausal women: report of three cases.
    El-Saghir NS; El-Hajj II; Makarem JA; Otrock ZK
    Anticancer Drugs; 2006 Sep; 17(8):999-1002. PubMed ID: 16940812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors of early distant recurrence in hormone receptor-positive, postmenopausal breast cancer patients receiving adjuvant tamoxifen therapy: results of a retrospective analysis.
    Debled M; MacGrogan G; Brouste V; Mathoulin-Pelissier S; Durand M; Mauriac L
    Cancer; 2007 Jun; 109(11):2197-204. PubMed ID: 17450590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma.
    Abner AL; Collins L; Peiro G; Recht A; Come S; Shulman LN; Silver B; Nixon A; Harris JR; Schnitt SJ; Connolly JL
    Cancer; 1998 Dec; 83(12):2502-8. PubMed ID: 9874455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postmastectomy radiotherapy of the chest wall. Comparison of electron-rotation technique and common tangential photon fields.
    Hehr T; Classen J; Huth M; Durst I; Christ G; Bamberg M; Budach W
    Strahlenther Onkol; 2004 Oct; 180(10):629-36. PubMed ID: 15480511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of axillary lymph node status of breast cancer patients by tumorbiological factors of the primary tumor.
    Fehm T; Maul H; Gebauer S; Scharf A; Baier P; Sohn C; Jäger W; Gebauer G
    Strahlenther Onkol; 2005 Sep; 181(9):580-6. PubMed ID: 16170485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.
    Delea TE; Karnon J; Smith RE; Johnston SR; Brandman J; Sung JC; Gross PE
    Am J Manag Care; 2006 Jul; 12(7):374-86. PubMed ID: 16834524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast cancer treatment guidelines in older women.
    Giordano SH; Hortobagyi GN; Kau SW; Theriault RL; Bondy ML
    J Clin Oncol; 2005 Feb; 23(4):783-91. PubMed ID: 15681522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A decision analysis of the effect of avoiding axillary lymph node dissection in low risk women with invasive breast carcinoma.
    Jackson JS; Olivotto IA; Wai M D E; Grau C; Mates D; Ragaz J
    Cancer; 2000 Apr; 88(8):1852-62. PubMed ID: 10760762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast cancer in women 80 years of age and older: a comprehensive analysis of an underreported entity.
    Vetter M; Huang DJ; Bosshard G; Güth U
    Acta Oncol; 2013 Jan; 52(1):57-65. PubMed ID: 23083423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NCCN Task Force Report: breast cancer in the older woman.
    Carlson RW; Moench S; Hurria A; Balducci L; Burstein HJ; Goldstein LJ; Gradishar WJ; Hughes KS; Jahanzeb M; Lichtman SM; Marks LB; McClure JS; McCormick B; Nabell LM; Pierce LJ; Smith ML; Topham NS; Traina TA; Ward JH; Winer EP
    J Natl Compr Canc Netw; 2008; 6 Suppl 4():S1-25; quiz S26-7. PubMed ID: 18597715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Breast cancer].
    Sakai T; Iwase T
    Gan To Kagaku Ryoho; 2010 Dec; 37(13):2829-32. PubMed ID: 21160258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Third revision of the National Consensus on Diagnosis and Treatment of Breast Cancer (third of three parts)].
    Ginecol Obstet Mex; 2010 Mar; 78(3):199-212. PubMed ID: 20939226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of breast cancer in the older woman.
    Balducci L; Extermann M; Carreca I
    Cancer Control; 2001; 8(5):431-41. PubMed ID: 11579340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.